ClearPoint Neuro (CLPT) Change in Cash (2011 - 2026)

ClearPoint Neuro has disclosed Change in Cash across 15 years of filings, most recently posting -$10.5 million for Q1 2026.

• Change in Cash for Q1 2026 came in at -$10.5 million, down 35.51% year-over-year; the trailing twelve-month figure through Mar 2026 was $24.1 million (up 205.06% YoY), and the FY2025 annual result was $26.9 million, up 985.01% from the prior year.
• Change in Cash came in at -$10.5 million for Q1 2026 at ClearPoint Neuro, down from $8.6 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $29.3 million in Q2 2025 to a low of -$26.1 million in Q2 2022.
• The 5-year median for Change in Cash is -$2.5 million (2024), against an average of -$1.0 million.
• Across the five-year window, Change in Cash tumbled 683.86% in 2022 and soared 1269.62% in 2025, its largest moves.
• ClearPoint Neuro's Change in Cash stood at $8.9 million in 2022, then slumped by 113.5% to -$1.2 million in 2023, then fell by 22.21% to -$1.5 million in 2024, then surged by 683.53% to $8.6 million in 2025, then sank by 221.99% to -$10.5 million in 2026.
• The last three Change in Cash figures came in at -$10.5 million (Q1 2026), $8.6 million (Q4 2025), and -$3.3 million (Q3 2025), per Business Quant data.